These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 32572786)

  • 1. Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants.
    Pestinger V; Smith M; Sillo T; Findlay JM; Laes JF; Martin G; Middleton G; Taniere P; Beggs AD
    Mol Diagn Ther; 2020 Aug; 24(4):505. PubMed ID: 32572786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.
    Cheng DT; Mitchell TN; Zehir A; Shah RH; Benayed R; Syed A; Chandramohan R; Liu ZY; Won HH; Scott SN; Brannon AR; O'Reilly C; Sadowska J; Casanova J; Yannes A; Hechtman JF; Yao J; Song W; Ross DS; Oultache A; Dogan S; Borsu L; Hameed M; Nafa K; Arcila ME; Ladanyi M; Berger MF
    J Mol Diagn; 2015 May; 17(3):251-64. PubMed ID: 25801821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology.
    Beg S; Bareja R; Ohara K; Eng KW; Wilkes DC; Pisapia DJ; Zoughbi WA; Kudman S; Zhang W; Rao R; Manohar J; Kane T; Sigouros M; Xiang JZ; Khani F; Robinson BD; Faltas BM; Sternberg CN; Sboner A; Beltran H; Elemento O; Mosquera JM
    Transl Oncol; 2021 Jan; 14(1):100944. PubMed ID: 33190043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers.
    Walker LC; Marquart L; Pearson JF; Wiggins GAR; O'Mara TA; Parsons MT; ; Barrowdale D; McGuffog L; Dennis J; Benitez J; Slavin TP; Radice P; Frost D; ; Godwin AK; Meindl A; Schmutzler RK; ; Isaacs C; Peshkin BN; Caldes T; Hogervorst FBL; ; Lazaro C; Jakubowska A; Montagna M; ; Chen X; Offit K; Hulick PJ; Andrulis IL; Lindblom A; Nussbaum RL; Nathanson KL; Chenevix-Trench G; Antoniou AC; Couch FJ; Spurdle AB
    Eur J Hum Genet; 2019 Jan; 27(1):167-168. PubMed ID: 30135485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Exome sequencing of Pakistani consanguineous families identifies 30 novel candidate genes for recessive intellectual disability.
    Riazuddin S; Hussain M; Razzaq A; Iqbal Z; Shahzad M; Polla DL; Song Y; van Beusekom E; Khan AA; Tomas-Roca L; Rashid M; Zahoor MY; Wissink-Lindhout WM; Basra MAR; Ansar M; Agha Z; van Heeswijk K; Rasheed F; Van de Vorst M; Veltman JA; Gilissen C; Akram J; Kleefstra T; Assir MZ; ; Grozeva D; Carss K; Raymond FL; O'Connor TD; Riazuddin SA; Khan SN; Ahmed ZM; de Brouwer APM; van Bokhoven H; Riazuddin S
    Mol Psychiatry; 2020 Nov; 25(11):3101-3102. PubMed ID: 30171209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.
    Oberg JA; Glade Bender JL; Sulis ML; Pendrick D; Sireci AN; Hsiao SJ; Turk AT; Dela Cruz FS; Hibshoosh H; Remotti H; Zylber RJ; Pang J; Diolaiti D; Koval C; Andrews SJ; Garvin JH; Yamashiro DJ; Chung WK; Emerson SG; Nagy PL; Mansukhani MM; Kung AL
    Genome Med; 2016 Dec; 8(1):133. PubMed ID: 28007021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Estimating the burden and economic impact of pediatric genetic disease.
    Gonzaludo N; Belmont JW; Gainullin VG; Taft RJ
    Genet Med; 2019 Sep; 21(9):2161. PubMed ID: 30760893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction to: Exosomes in Cardiovascular Medicine.
    Dykes IM
    Cardiol Ther; 2018 Jun; 7(1):125. PubMed ID: 29520573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and Immunotherapies.
    Cao J; Chen L; Li H; Chen H; Yao J; Mu S; Liu W; Zhang P; Cheng Y; Liu B; Hu Z; Chen D; Kang H; Hu J; Wang A; Wang W; Yao M; Chrin G; Wang X; Zhao W; Li L; Xu L; Guo W; Jia J; Chen J; Wang K; Li G; Shi W
    Oncologist; 2019 Dec; 24(12):e1294-e1302. PubMed ID: 31409745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Hopefully devoted to Q: targeting glutamine addiction in cancer.
    Still ER; Yuneva MO
    Br J Cancer; 2019 Apr; 120(9):957. PubMed ID: 30867565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma.
    Tetzlaff MT; Singh RR; Seviour EG; Curry JL; Hudgens CW; Bell D; Wimmer DA; Ning J; Czerniak BA; Zhang L; Davies MA; Prieto VG; Broaddus RR; Ram P; Luthra R; Esmaeli B
    J Pathol; 2016 Sep; 240(1):84-95. PubMed ID: 27287813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
    Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Author Correction: The wide utility of rabbits as models of human diseases.
    Esteves PJ; Abrantes J; Baldauf HM; BenMohamed L; Chen Y; Christensen N; González-Gallego J; Giacani L; Hu J; Kaplan G; Keppler OT; Knight KL; Kong XP; Lanning DK; Le Pendu J; de Matos AL; Liu J; Liu S; Lopes AM; Lu S; Lukehart S; Manabe YC; Neves F; McFadden G; Pan R; Peng X; de Sousa-Pereira P; Pinheiro A; Rahman M; Ruvoën-Clouet N; Subbian S; Tuñón MJ; van der Loo W; Vaine M; Via LE; Wang S; Mage R
    Exp Mol Med; 2019 Jul; 51(7):1. PubMed ID: 31270317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: The Relative Contribution of Metabolic and Structural Abnormalities to Diastolic Dysfunction in Obesity.
    Rayner JJ; Banerjee R; Holloway CJ; Lewis AJM; Peterzan MA; Francis JM; Neubauer S; Rider OJ
    Int J Obes (Lond); 2019 Aug; 43(8):1652. PubMed ID: 31227797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying a wide range of actionable variants using capture-based ultra-deep targeted sequencing in treatment-naive patients with primary lung adenocarcinoma.
    Chen L; Chen M; Lin J; Chen X; Yu X; Chen Z; Jin L
    Int J Clin Exp Pathol; 2020; 13(3):525-535. PubMed ID: 32269691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
    Luchini C; Bibeau F; Ligtenberg MJL; Singh N; Nottegar A; Bosse T; Miller R; Riaz N; Douillard JY; Andre F; Scarpa A
    Ann Oncol; 2019 Aug; 30(8):1232-1243. PubMed ID: 31056702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Publisher Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration.
    Höglund K; Kern S; Zettergren A; Börjesson-Hansson A; Zetterberg H; Skoog I; Blennow K
    Transl Psychiatry; 2018 Nov; 8(1):250. PubMed ID: 30455463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of a cancer genomic profiling assay to guide precision medicine decisions.
    Eifert C; Pantazi A; Sun R; Xu J; Cingolani P; Heyer J; Russell M; Lvova M; Ring J; Tse JY; Lyle S; Protopopov A
    Per Med; 2017 Jul; 14(4):309-325. PubMed ID: 28890729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures.
    Kim H; Lee AJ; Lee J; Chun H; Ju YS; Hong D
    Genome Med; 2019 Dec; 11(1):81. PubMed ID: 31847917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Patient experience and utility of genetic information: a cross-sectional study among patients tested for cancer susceptibility and thrombophilia.
    D'Andrea E; Lagerberg T; De Vito C; Pitini E; Marzuillo C; Massimi A; Vacchio MR; Grammatico P; Villari P
    Eur J Hum Genet; 2018 Sep; 26(9):1398. PubMed ID: 29980747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.